Champix - direct healthcare professional communication (DHPC)

varenicline

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Documents

Direct healthcare professional communication (DHPC): Champix (varenicline) - lots to be recalled due to presence of impurity N-nitroso-varenicline above the Pfizer acceptable daily intake limit

Dissemination date: 15/07/2021

Key facts

• Medicine name:
  Champix
• Active substance:
  varenicline
• Therapeutic area (MeSH):
  Tobacco Use Cessation
• Procedure number:
  EMEA/H/C/000699
• DHPC type:
  Quality defect
• Human ATC codes:
  N07BA03
• Dissemination date:
  15/07/2021